BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

280 related articles for article (PubMed ID: 32165406)

  • 21. Low-dose-rate californium-252 neutron intracavitary afterloading radiotherapy combined with conformal radiotherapy for treatment of cervical cancer.
    Zhang M; Xu HD; Pan SD; Lin S; Yue JH; Liu JR
    Int J Radiat Oncol Biol Phys; 2012 Jul; 83(3):966-71. PubMed ID: 22138462
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Long-term outcomes of concomitant chemoradiotherapy incorporating high-dose-rate brachytherapy to treat locally advanced cervical cancer.
    Lee HJ; Kim YS; Shin SS; Nam JH; Kim YT; Han S; Choi EK
    Tumori; 2012; 98(5):615-21. PubMed ID: 23235757
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Long-term effectiveness and safety of image-based, transperineal combined intracavitary and interstitial brachytherapy in treatment of locally advanced cervical cancer.
    Tiwari R; Narayanan GS; Narayanan S; Suresh Kumar P
    Brachytherapy; 2020; 19(1):73-80. PubMed ID: 31813739
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effectiveness of Image-guided Brachytherapy in Patients With Locally Advanced Cervical Squamous Cell Carcinoma Receiving Concurrent Chemoradiotherapy.
    Chen SW; Liang JA; Hung YC; Yeh LS; Chang WC; Lin WC; Chang YY
    Anticancer Res; 2019 Jun; 39(6):3015-3024. PubMed ID: 31177143
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical outcomes of definitive chemoradiation followed by intracavitary pulsed-dose rate image-guided adaptive brachytherapy in locally advanced cervical cancer.
    Castelnau-Marchand P; Chargari C; Maroun P; Dumas I; Del Campo ER; Cao K; Petit C; Martinetti F; Tafo-Guemnie A; Lefkopoulos D; Morice P; Haie-Meder C; Mazeron R
    Gynecol Oncol; 2015 Nov; 139(2):288-94. PubMed ID: 26364808
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of tumor dose, volume and overall treatment time on local control after radiochemotherapy including MRI guided brachytherapy of locally advanced cervical cancer.
    Tanderup K; Fokdal LU; Sturdza A; Haie-Meder C; Mazeron R; van Limbergen E; Jürgenliemk-Schulz I; Petric P; Hoskin P; Dörr W; Bentzen SM; Kirisits C; Lindegaard JC; Pötter R
    Radiother Oncol; 2016 Sep; 120(3):441-446. PubMed ID: 27350396
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparison of Computed Tomography- and Magnetic Resonance Imaging-based Clinical Target Volume Contours at Brachytherapy for Cervical Cancer.
    Swanick CW; Castle KO; Vedam S; Munsell MF; Turner LM; Rauch GM; Jhingran A; Eifel PJ; Klopp AH
    Int J Radiat Oncol Biol Phys; 2016 Nov; 96(4):793-800. PubMed ID: 27788952
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Concomitant chemobrachyradiotherapy with ifosfamide and cisplatin followed by consolidation chemotherapy for women with locally advanced carcinoma of the uterine cervix--final results of a prospective phase II-study.
    Vrdoljak E; Omrcen T; Novaković ZS; Jelavić TB; Prskalo T; Hrepić D; Hamm W
    Gynecol Oncol; 2006 Nov; 103(2):494-9. PubMed ID: 16814371
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Concomitant Chemoradiotherapy With Image-guided Pulsed Dose Rate Brachytherapy as a Definitive Treatment Modality for Early-stage Cervical Cancer.
    Refaat T; Castelain B; Small W; Elsaid A; Lotfy N; Lartigau E; Nickers P
    Am J Clin Oncol; 2015 Jun; 38(3):289-93. PubMed ID: 23799285
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Clinical results of combined intracavitary-interstitial image-guided adaptive brachytherapy in locally advanced cervical cancer].
    Vízkeleti J; Fröhlich G; Nhung NA; Horváth K; Major T; Polgár C
    Magy Onkol; 2018 Dec; 62(4):249-257. PubMed ID: 30540868
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dose optimization of fractionated external radiation and high-dose-rate intracavitary brachytherapy for FIGO stage IB uterine cervical carcinoma.
    Lee SW; Suh CO; Chung EJ; Kim GE
    Int J Radiat Oncol Biol Phys; 2002 Apr; 52(5):1338-44. PubMed ID: 11955747
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Impact of pre-brachytherapy magnetic resonance imaging on dose-volume histogram of locally advanced cervical cancer patients treated with radiotherapy including high-dose-rate brachytherapy.
    Murofushi KN; Ishida T; Baba K; Kawakita K; Sasaki TS; Okumura T; Sato T; Sakurai H
    J Contemp Brachytherapy; 2021 Feb; 13(1):32-38. PubMed ID: 34025734
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Concurrent chemoradiotherapy incorporating high-dose rate brachytherapy for locally advanced cervical carcinoma: survival outcomes, patterns of failure, and prognostic factors.
    Teh J; Yap SP; Tham I; Sethi VK; Chua EJ; Yeo R; Ho TH; Tay EH; Chia YN; Soh LT; Khoo-Tan HS
    Int J Gynecol Cancer; 2010 Apr; 20(3):428-33. PubMed ID: 20375809
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A phase II trial of less than 7 weeks of concomitant cisplatin-paclitaxel chemoradiation in locally advanced cervical cancer.
    Martínez-Monge R; Gaztañaga M; Aramendía JM; Cambeiro M; Arbea L; Espinós J; Aristu JJ; Jurado M
    Int J Gynecol Cancer; 2010 Jan; 20(1):133-40. PubMed ID: 20130514
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Phase I clinical trial of weekly paclitaxel, weekly carboplatin, and concurrent radiotherapy for primary cervical cancer.
    Rao GG; Rogers P; Drake RD; Nguyen P; Coleman RL
    Gynecol Oncol; 2005 Jan; 96(1):168-72. PubMed ID: 15589596
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Early clinical outcomes of ultrasound-guided CT-planned high-dose-rate interstitial brachytherapy for primary locally advanced cervical cancer.
    Mesko S; Swamy U; Park SJ; Borja L; Wang J; Demanes DJ; Kamrava M
    Brachytherapy; 2015; 14(5):626-32. PubMed ID: 26024784
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Change in image-guided planning strategies over time impacts oncologic and survival outcomes for intracavitary cervical cancer brachytherapy.
    D'Cunha P; Gonzalez Y; Nwachukwu C; Hrycushko B; Medin P; Owrangi A; Jia X; Albuquerque K
    Brachytherapy; 2022; 21(5):668-677. PubMed ID: 35871130
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A comparison of intracavitary versus interstitial irradiation in the treatment of cervical cancer.
    Monk BJ; Tewari K; Burger RA; Johnson MT; Montz FJ; Berman ML
    Gynecol Oncol; 1997 Dec; 67(3):241-7. PubMed ID: 9441770
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Treatment results of high-dose-rate remote afterloading brachytherapy for cervical cancer and retrospective comparison of two regimens.
    Wong FC; Tung SY; Leung TW; Sze WK; Wong VY; Lui CM; Yuen KK; O SK
    Int J Radiat Oncol Biol Phys; 2003 Apr; 55(5):1254-64. PubMed ID: 12654435
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Residual tumour volumes and grey zones after external beam radiotherapy (with or without chemotherapy) in cervical cancer patients. A low-field MRI study.
    Schmid MP; Mansmann B; Federico M; Dimopoulous JC; Georg P; Fidarova E; Dörr W; Pötter R
    Strahlenther Onkol; 2013 Mar; 189(3):238-44. PubMed ID: 23344563
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.